Fingerprint
Dive into the research topics of 'Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma
Amrita Krishnan, Prashant Kapoor, Joycelynne M. Palmer, Ni Chun Tsai, Shaji Kumar, Sagar Lonial, Myo Htut, Chatchada Karanes, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, George Somlo, Lupe Duarte, James F. Sanchez, Daniel Auclair, Stephen J. Forman, Jesus G. Berdeja
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations